Lumenis

Lumenis, established in 1966, is a prominent entity in the Medical Devices & Equipment and Manufacturing sectors. The company specializes in the development and commercialization of advanced energy-based technologies tailored for skin, body, and eye care treatments. Its product portfolio includes innovative solutions such as trilift, optilight, stellar M22, optiplus, and digital duet, underscoring its commitment to technological advancement in healthcare. Operating from Hesse, Germany, Lumenis has built a reputation for delivering cutting-edge medical equipment and clinical solutions.

With a substantial operational footprint, Lumenis employs between 1,000 and 5,000 individuals across 41 locations globally. This scale of operation supports its mission to provide effective medical treatments and devices. The company's focus on energy-based technologies extends to aesthetic, vision, surgical, and ophthalmology applications, positioning it as a key player in these specialized medical fields. Interested parties can learn more about the individuals driving these advancements by visiting Meet Lumenis's team. This team is dedicated to pushing the boundaries of medical technology and patient care.

Financially, Lumenis has demonstrated significant market presence, reporting revenue of $363.0M. The company has also undergone strategic financial activities, including a $120 million private equity round in September 2006 led by XT Group, and a $75 million stock issuance in February 2014. These financial milestones reflect its growth trajectory and investment in innovation. For a detailed breakdown of its financial performance and investment history, users can Explore financial highlights. Lumenis continues to invest in research and development to maintain its leadership in energy-based medical technologies.